[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13â16 June 2018 - ()] THURSDAY, 14 JUNE 2018 - THU0191â Novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial
Westhovens, R., Yoo, D.H., Jaworski, J., Matyska-Piekarska, E., Smiyan, S., Ivanova, D., Zielinska, A., Raussi, E.-K., Batalov, A., Lee, S.J., Lee, S.Y., Suh, J.H.DOI:
10.1136/annrheumdis-2018-eular.1810
File:
PDF, 415 KB